Related references
Note: Only part of the references are listed.O6-Methylguanine DNA Methyltransferase Immunoexpression in Nonfunctioning Pituitary Adenomas Are Progressive Tumors Potential Candidates for Temozolomide Treatment?
Georg Widhalm et al.
CANCER (2009)
Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours
Ann I. McCormack et al.
CLINICAL ENDOCRINOLOGY (2009)
Treatment of Nelson's syndrome with temozolomide
V. J. Moyes et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy
C. Hagen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
RADIOSENSITIZING EFFECTS OF TEMOZOLOMIDE OBSERVED IN VIVO ONLY IN A SUBSET OF O6-METHYLGUANINE-DNA METHYLTRANSFERASE METHYLATED GLIOBLASTOMA MULTIFORME XENOGRAFTS
Brett L. Carlson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
USE OF TEMOZOLOMIDE IN AGGRESSIVE PITUITARY TUMORS: CASE REPORT
Safraz Mohammed et al.
NEUROSURGERY (2009)
Multimodality Treatment for Invasive Pituitary Adenomas
Mark Hornyak et al.
POSTGRADUATE MEDICINE (2009)
In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomide
Whoon Jong Kil et al.
CLINICAL CANCER RESEARCH (2008)
Correlation of O6-Methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
Monika E. Hegi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Differential radiosensitizing potential of temozolomide in mgmt promoter methylated glioblastoma multiforme cell lines
Krista A. Van Nifterik et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Temozolomide in the treatment of an invasive prolactinoma resistant to dopamine agonists
Lisa M. Neff et al.
PITUITARY (2007)
Temozolomide therapy in a man with an aggressive prolactin-secreting pituitary neoplasm: morphological findings
Kalman Kovacs et al.
HUMAN PATHOLOGY (2007)
Antitumour effects of temozolomide in a man with a large, invasive prolactin-producing pituitary neoplasm
Luis V. Syro et al.
CLINICAL ENDOCRINOLOGY (2006)
Long-term response of pituitary carcinoma to temozolomide - Report of two cases
Camilo E. Fadul et al.
JOURNAL OF NEUROSURGERY (2006)
Share Paper
